Robin Taneja's Bail Cancelled Amid Allegations of Forgery and Illicit Drug Distribution
The Bombay High Court's Nagpur Bench has annulled the bail granted to Robin alias Himanshu Vijaykumar Taneja, accused in a high-profile case involving the manufacturing and distribution of spurious drugs. The decision was delivered by Justice M.M. Nerlikar on March 24, 2026, in response to an application filed by the State of Maharashtra.
The case, initially registered as Crime No.57/2024 with Kalmeshwar Police Station, Nagpur, involves serious allegations against Taneja and others under various sections of the Indian Penal Code, including forgery and conspiracy, as well as violations of the Drugs and Cosmetics Act, 1940. The investigation revealed a network of illegal transactions and the distribution of counterfeit drugs, purported to be Ciprofloxacin, to government hospitals, posing grave risks to public health.
Justice Nerlikar highlighted the lack of legitimate transactions between Taneja and the alleged drug manufacturer, Amit Dhiman, who lacked a valid license for human drug production. Despite significant monetary transfers from co-accused Vijay Choudhary and others to Taneja and his family, no similar transactions were evident with Dhiman, suggesting Taneja's awareness and involvement in the illicit operations.
The court criticized the trial court's earlier decision to grant bail, pointing out the oversight of critical financial transactions and the potential threat posed by Taneja's alleged actions to public health and safety. The judgment underscores the judiciary's commitment to addressing the complexities of such cases and ensuring accountability.
The cancellation of bail is a significant development in the ongoing legal proceedings against Taneja, who faces charges including forgery, conspiracy, and the distribution of spurious drugs. This case serves as a stark reminder of the pervasive threat of counterfeit drugs and the stringent measures required to combat such criminal enterprises.
Bottom Line:
Bail granted to the accused involved in manufacturing and distribution of spurious drugs set aside considering the seriousness of the crime, monetary transactions, and forged labels, indicating the accused's active involvement and knowledge of the illegality.
Statutory provision(s): Indian Penal Code Sections 420, 467, 468, 471, 274, 275, 276, 120B, 34; Drugs and Cosmetics Act, 1940
